NextGen Healthcare (NXGN) Reports In-Line Q1 EPS, Lowers FY Guidance

NextGen Healthcare (NASDAQ: NXGN) reported Q1 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $153.3 million versus the consensus estimate of $152.89 million.

GUIDANCE:

NextGen Healthcare sees FY2023 EPS of $0.92-$0.98, versus the consensus of $0.98. NextGen Healthcare sees FY2023 revenue of $621-633 million, versus the consensus of $634 million.

For earnings history and earnings-related data on NextGen Healthcare (NXGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c